Business Description
Medicus Pharma Ltd
NAICS : 325412
SIC : 3741
ISIN : CA58471K1030
Description
Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 15.2 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate | 17.02 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.79 | |||||
| 9-Day RSI | 40.83 | |||||
| 14-Day RSI | 43.39 | |||||
| 6-1 Month Momentum % | 111.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.73 | |||||
| Quick Ratio | 2.73 | |||||
| Cash Ratio | 2.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 4.34 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -428.49 | |||||
| ROA % | -260.31 | |||||
| ROIC % | -697.56 | |||||
| ROC (Joel Greenblatt) % | -768.89 | |||||
| ROCE % | -401.09 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 9.06 | |||||
| Price-to-Tangible-Book | 8.81 | |||||
| EV-to-EBIT | -2.51 | |||||
| EV-to-Forward-EBIT | -2.01 | |||||
| EV-to-EBITDA | -2.53 | |||||
| EV-to-FCF | -2.82 | |||||
| Price-to-Net-Current-Asset-Value | 9.92 | |||||
| Price-to-Net-Cash | 10.35 | |||||
| Earnings Yield (Greenblatt) % | -39.84 | |||||
| FCF Yield % | -30.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicus Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.269 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 43.39 | ||
| 14-Day ATR (€) | 0.054407 | ||
| 20-Day SMA (€) | 2.3815 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 1.14 - 4.04 | ||
| Shares Outstanding (Mil) | 11.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicus Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicus Pharma Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medicus Pharma Ltd Frequently Asked Questions
What is Medicus Pharma Ltd(FRA:N460)'s stock price today?
The current price of FRA:N460 is €2.38. The 52 week high of FRA:N460 is €4.04 and 52 week low is €1.14.
When is next earnings date of Medicus Pharma Ltd(FRA:N460)?
The next earnings date of Medicus Pharma Ltd(FRA:N460) is .
Does Medicus Pharma Ltd(FRA:N460) pay dividends? If so, how much?
Medicus Pharma Ltd(FRA:N460) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers